期刊文献+

Pediatric fatty liver disease:Role of ethnicity and genetics 被引量:5

Pediatric fatty liver disease:Role of ethnicity and genetics
下载PDF
导出
摘要 Non-alcoholic fatty liver disease (NAFLD) comprehends a wide range of conditions, encompassing from fatty liver or steatohepatitis with or without fibrosis, to cirrhosis and its complications. NAFLD has become the most common form of liver disease in childhood as its prevalence has more than doubled over the past 20 years, paralleling the increased prevalence of childhood obesity. It currently affects between 3% and 11% of the pediatric population reaching the rate of 46% among overweight and obese children and adolescents. The prevalence of hepatic steatosis varies among different ethnic groups. The ethnic group with the highest prevalence is the Hispanic one followed by the Caucasian and the African-American. This evidence suggests that there is a strong genetic background in the predisposition to fatty liver. In fact, since 2008 several common gene variants have been implicated in the pathogenesis of fatty liver disease. The most important is probably the patatin like phospholipase containing domain 3 gene (PNPLA3) discovered by the Hobbs’ group in 2008. This article reviews the current knowledge regarding the role of ethnicity and genetics in pathogenesis of pediatric fatty liver. Non-alcoholic fatty liver disease(NAFLD)comprehends a wide range of conditions,encompassing from fatty liver or steatohepatitis with or without fibrosis,to cirrhosis and its complications.NAFLD has become the most common form of liver disease in childhood as its prevalence has more than doubled over the past 20years,paralleling the increased prevalence of childhood obesity.It currently affects between 3%and11%of the pediatric population reaching the rate of46%among overweight and obese children and adolescents.The prevalence of hepatic steatosis varies among different ethnic groups.The ethnic group with the highest prevalence is the Hispanic one followed by the Caucasian and the African-American.This evidence suggests that there is a strong genetic background in the predisposition to fatty liver.In fact,since 2008several common gene variants have been implicated in the pathogenesis of fatty liver disease.The most important is probably the patatin like phospholipase containing domain 3 gene(PNPLA3)discovered by the Hobbs’group in 2008.This article reviews the current knowledge regarding the role of ethnicity and genetics in pathogenesis of pediatric fatty liver.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第23期7347-7355,共9页 世界胃肠病学杂志(英文版)
基金 Supported by The American Heart Association(13SDG14640038) 2012 Yale Center for Clinical Investigation cholar award to Santoro N This publication was also made possible by CTSA Grant Number UL1 RR024139 from the National Center for Advancing Translational Science,a component of the National Institutes of Health(NIH),and NIH roadmap for Medical Research,Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH
  • 相关文献

参考文献12

  • 1Lucia Pacifico,Michele Di Martino,Carlo Catalano,Valeria Panebianco,Mario Bezzi,Caterina Anania,Claudio Chiesa.T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2011,17(25):3012-3019. 被引量:10
  • 2Lucia Pacifico,Eleonora Poggiogalle,Vito Cantisani,Guendalina Menichini,Paolo Ricci,Flavia Ferraro,Claudio Chiesa.Pediatric nonalcoholic fatty liver disease:A clinical and laboratory challenge[J].World Journal of Hepatology,2010,2(7):275-288. 被引量:6
  • 3Takuya Kitamoto,Aya Kitamoto,Masato Yoneda,Hideyuki Hyogo,Hidenori Ochi,Takahiro Nakamura,Hajime Teranishi,Seiho Mizusawa,Takato Ueno,Kazuaki Chayama,Atsushi Nakajima,Kazuwa Nakao,Akihiro Sekine,Kikuko Hotta.Genome-wide scan revealed that polymorphisms in the PNPLA3 , SAMM50 , and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan[J].Human Genetics.2013(7)
  • 4Li, John Zhong,Huang, Yongcheng,Karaman, Ruchan,Ivanova, Pavlina T,Brown, H Alex,Roddy, Thomas,Castro-Perez, Jose,Cohen, Jonathan C,Hobbs, Helen H.Chronic overexpression of PNPLA3^sup I148M^ in mouse liver causes hepatic steatosis[J]. EN . 2012 (11)
  • 5D. Compare,P. Coccoli,A. Rocco,O.M. Nardone,S. De Maria,M. Cartenì,G. Nardone.Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease[J].Nutrition Metabolism and Cardiovascular Diseases.2012(6)
  • 6Jean A. Welsh,Saul Karpen,Miriam B. Vos.Increasing Prevalence of Nonalcoholic Fatty Liver Disease Among United States Adolescents, 1988-1994 to 2007-2010[J].The Journal of Pediatrics.2012
  • 7Angela Shannon,Naim Alkhouri,Christine Carter-Kent,Lidia Monti,Rita Devito,Rocio Lopez,Ariel E. Feldstein,Valerio Nobili.Ultrasonographic Quantitative Estimation of Hepatic Steatosis in Children With NAFLD[J].Journal of Pediatric Gastroenterology and Nutrition.2011(2)
  • 8Fatima Zahra Aly,David E. Kleiner.Update on Fatty Liver Disease and Steatohepatitis[J].Advances in Anatomic Pathology.2011(4)
  • 9.Quantitative Analysis of Adipose Tissue in Single Transverse Slices for Estimation of Volumes of Relevant Fat Tissue Compartments: A Study in a Large Cohort of Subjects at Risk for Type 2 Diabetes by MRI With Comparison to Anthropometric Data[J].Investigative Radiology.2010(12)
  • 10Meetings[J].World Journal of Gastroenterology,2010,16(5). 被引量:14

二级参考文献173

  • 1D'Adamo E, Cali AM, Weiss R, Santoro N, Pierpont B, Northrup V, Caprio S. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 2010; 33: 1817-1822.
  • 2Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A. MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pe- diatric nonalcoholic fatty liver disease. Acta Paediatr 2007; 96:542-547.
  • 3Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, Doo E, Ghany M, Premkumar A, Park Y, Liang TJ, Yanovski JA, Kleiner DE, Hoofnagle JH. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 2004; 39:188-196.
  • 4Schwenzer NF, Machann J, Martirosian P, Stefan N, Sch- raml C, Fritsche A, Claussen CD, Schick F. Quantificationof pancreatic lipomatosis and liver steatosis by MRh com- parison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol 2008; 43:330-337.
  • 5Younossi ZM, Gramlich T, Bacon BR, Matteoni CA, Boparai N, O'Neill R, McCullough AJ. Hepatic iron and nonalcoholic fatty liver disease. Hepatology 1999; 30:847-850.
  • 6McPherson S, Jonsson JR, Cowin GJ, O'Rourke P, Clouston AD, Volp A, Horsfall L, Jothimani D, Fawcett J, Galloway GJ, Benson M, Powell EE. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepato12009; 51: 389-397.
  • 7Lee SS, Park SH, Kim HJ, Kim SY, Kim MY, Kim DY, Suh DJ, Kim KM, Bae MH, Lee JY, Lee SG, Yu ES. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 2010; 52: 579-585.
  • 8Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp- Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatologv 2005; 41:1313-1321.
  • 9Pacifico L, Cantisani V, Ricci P, Osborn JF, Schiavo E, Ana- nia C, Ferrara E, Dvisic G, Chiesa C. Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 2008; 63- 423-427.
  • 10Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity world- wide: international survey. BM12000; 320:1240-1243.

共引文献34

同被引文献23

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部